Psoriasis and cardiovascular disease risk in European and East Asian populations: evidence from meta-analysis and Mendelian randomization analysis
Background Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF). However, available studies regarding this relationship have shown inconsistent results. Therefore, in this report, we performed a compreh...
Saved in:
| Published in | BMC medicine Vol. 20; no. 1; pp. 1 - 11 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central Ltd
01.11.2022
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Background Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF). However, available studies regarding this relationship have shown inconsistent results. Therefore, in this report, we performed a comprehensive review of the literature to assess the effects of psoriasis on risk of these CVDs. Methods A search of literature until 24 December 2021 was done in PubMed, the Cochrane Library, Web of Science, Google Scholar, and Embase. Within European and East Asian populations, meta-analyses of observational studies assessing correlations between psoriasis and various CVD risk factors were conducted. Mendelian randomization (MR) was then employed to assess the causative impact of genetic pre-disposition for psoriasis on these CVD risk factors. Results The results of the meta-analyses indicated that, in both the European and East Asian populations, psoriasis was significantly linked to an elevated risk in the incidence of CAD (RR = 1.51, 95% confidence interval (CI): 1.04-2.18, p = 0.028 and RR = 1.91, 95% CI: 1.62-2.25, p < 0.001) and MI (RR = 1.23, 95% CI: 1.04-1.46, p = 0.017 and RR = 2.17, 95% CI: 1.44-3.28, p < 0.001). A positive genetic relationship of psoriasis with CAD was found in European individuals (IVW OR:1.03; 95% CI: 1.01-1.06, p = 0.005) and in East Asian individuals (IVW OR:1.18; 95% CI: 1.03-1.32, p = 0.031). We also established that psoriasis was causally linked with an elevated risk of MI (IVW OR:1.05; 95% CI: 1.01-1.09, p = 0.026) in the European population as determined using an MR approach. Moreover, our MR results were congruent with the null findings from the meta-analysis assessing associations of psoriasis with HF risk. Conclusions This research work provides preliminary evidence that psoriasis and CVD have a common genetic origin and that targeted psoriasis treatment might improve cardiovascular outcomes. These results not only increase our knowledge of the genetic underpinnings linking a comorbidity of psoriasis with CVD but also suggests a novel approach for CVD prevention. Keywords: Cardiovascular disease, Psoriasis, Mendelian randomization |
|---|---|
| AbstractList | Background Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF). However, available studies regarding this relationship have shown inconsistent results. Therefore, in this report, we performed a comprehensive review of the literature to assess the effects of psoriasis on risk of these CVDs. Methods A search of literature until 24 December 2021 was done in PubMed, the Cochrane Library, Web of Science, Google Scholar, and Embase. Within European and East Asian populations, meta-analyses of observational studies assessing correlations between psoriasis and various CVD risk factors were conducted. Mendelian randomization (MR) was then employed to assess the causative impact of genetic pre-disposition for psoriasis on these CVD risk factors. Results The results of the meta-analyses indicated that, in both the European and East Asian populations, psoriasis was significantly linked to an elevated risk in the incidence of CAD (RR = 1.51, 95% confidence interval (CI): 1.04-2.18, p = 0.028 and RR = 1.91, 95% CI: 1.62-2.25, p < 0.001) and MI (RR = 1.23, 95% CI: 1.04-1.46, p = 0.017 and RR = 2.17, 95% CI: 1.44-3.28, p < 0.001). A positive genetic relationship of psoriasis with CAD was found in European individuals (IVW OR:1.03; 95% CI: 1.01-1.06, p = 0.005) and in East Asian individuals (IVW OR:1.18; 95% CI: 1.03-1.32, p = 0.031). We also established that psoriasis was causally linked with an elevated risk of MI (IVW OR:1.05; 95% CI: 1.01-1.09, p = 0.026) in the European population as determined using an MR approach. Moreover, our MR results were congruent with the null findings from the meta-analysis assessing associations of psoriasis with HF risk. Conclusions This research work provides preliminary evidence that psoriasis and CVD have a common genetic origin and that targeted psoriasis treatment might improve cardiovascular outcomes. These results not only increase our knowledge of the genetic underpinnings linking a comorbidity of psoriasis with CVD but also suggests a novel approach for CVD prevention. Keywords: Cardiovascular disease, Psoriasis, Mendelian randomization Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF). However, available studies regarding this relationship have shown inconsistent results. Therefore, in this report, we performed a comprehensive review of the literature to assess the effects of psoriasis on risk of these CVDs.BACKGROUNDPsoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF). However, available studies regarding this relationship have shown inconsistent results. Therefore, in this report, we performed a comprehensive review of the literature to assess the effects of psoriasis on risk of these CVDs.A search of literature until 24 December 2021 was done in PubMed, the Cochrane Library, Web of Science, Google Scholar, and Embase. Within European and East Asian populations, meta-analyses of observational studies assessing correlations between psoriasis and various CVD risk factors were conducted. Mendelian randomization (MR) was then employed to assess the causative impact of genetic pre-disposition for psoriasis on these CVD risk factors.METHODSA search of literature until 24 December 2021 was done in PubMed, the Cochrane Library, Web of Science, Google Scholar, and Embase. Within European and East Asian populations, meta-analyses of observational studies assessing correlations between psoriasis and various CVD risk factors were conducted. Mendelian randomization (MR) was then employed to assess the causative impact of genetic pre-disposition for psoriasis on these CVD risk factors.The results of the meta-analyses indicated that, in both the European and East Asian populations, psoriasis was significantly linked to an elevated risk in the incidence of CAD (RR = 1.51, 95% confidence interval (CI): 1.04-2.18, p = 0.028 and RR = 1.91, 95% CI: 1.62-2.25, p < 0.001) and MI (RR = 1.23, 95% CI: 1.04-1.46, p = 0.017 and RR = 2.17, 95% CI: 1.44-3.28, p < 0.001). A positive genetic relationship of psoriasis with CAD was found in European individuals (IVW OR:1.03; 95% CI: 1.01-1.06, p = 0.005) and in East Asian individuals (IVW OR:1.18; 95% CI: 1.03-1.32, p = 0.031). We also established that psoriasis was causally linked with an elevated risk of MI (IVW OR:1.05; 95% CI: 1.01-1.09, p = 0.026) in the European population as determined using an MR approach. Moreover, our MR results were congruent with the null findings from the meta-analysis assessing associations of psoriasis with HF risk.RESULTSThe results of the meta-analyses indicated that, in both the European and East Asian populations, psoriasis was significantly linked to an elevated risk in the incidence of CAD (RR = 1.51, 95% confidence interval (CI): 1.04-2.18, p = 0.028 and RR = 1.91, 95% CI: 1.62-2.25, p < 0.001) and MI (RR = 1.23, 95% CI: 1.04-1.46, p = 0.017 and RR = 2.17, 95% CI: 1.44-3.28, p < 0.001). A positive genetic relationship of psoriasis with CAD was found in European individuals (IVW OR:1.03; 95% CI: 1.01-1.06, p = 0.005) and in East Asian individuals (IVW OR:1.18; 95% CI: 1.03-1.32, p = 0.031). We also established that psoriasis was causally linked with an elevated risk of MI (IVW OR:1.05; 95% CI: 1.01-1.09, p = 0.026) in the European population as determined using an MR approach. Moreover, our MR results were congruent with the null findings from the meta-analysis assessing associations of psoriasis with HF risk.This research work provides preliminary evidence that psoriasis and CVD have a common genetic origin and that targeted psoriasis treatment might improve cardiovascular outcomes. These results not only increase our knowledge of the genetic underpinnings linking a comorbidity of psoriasis with CVD but also suggests a novel approach for CVD prevention.CONCLUSIONSThis research work provides preliminary evidence that psoriasis and CVD have a common genetic origin and that targeted psoriasis treatment might improve cardiovascular outcomes. These results not only increase our knowledge of the genetic underpinnings linking a comorbidity of psoriasis with CVD but also suggests a novel approach for CVD prevention. Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF). However, available studies regarding this relationship have shown inconsistent results. Therefore, in this report, we performed a comprehensive review of the literature to assess the effects of psoriasis on risk of these CVDs. A search of literature until 24 December 2021 was done in PubMed, the Cochrane Library, Web of Science, Google Scholar, and Embase. Within European and East Asian populations, meta-analyses of observational studies assessing correlations between psoriasis and various CVD risk factors were conducted. Mendelian randomization (MR) was then employed to assess the causative impact of genetic pre-disposition for psoriasis on these CVD risk factors. The results of the meta-analyses indicated that, in both the European and East Asian populations, psoriasis was significantly linked to an elevated risk in the incidence of CAD (RR = 1.51, 95% confidence interval (CI): 1.04-2.18, p = 0.028 and RR = 1.91, 95% CI: 1.62-2.25, p < 0.001) and MI (RR = 1.23, 95% CI: 1.04-1.46, p = 0.017 and RR = 2.17, 95% CI: 1.44-3.28, p < 0.001). A positive genetic relationship of psoriasis with CAD was found in European individuals (IVW OR:1.03; 95% CI: 1.01-1.06, p = 0.005) and in East Asian individuals (IVW OR:1.18; 95% CI: 1.03-1.32, p = 0.031). We also established that psoriasis was causally linked with an elevated risk of MI (IVW OR:1.05; 95% CI: 1.01-1.09, p = 0.026) in the European population as determined using an MR approach. Moreover, our MR results were congruent with the null findings from the meta-analysis assessing associations of psoriasis with HF risk. This research work provides preliminary evidence that psoriasis and CVD have a common genetic origin and that targeted psoriasis treatment might improve cardiovascular outcomes. These results not only increase our knowledge of the genetic underpinnings linking a comorbidity of psoriasis with CVD but also suggests a novel approach for CVD prevention. Background Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF). However, available studies regarding this relationship have shown inconsistent results. Therefore, in this report, we performed a comprehensive review of the literature to assess the effects of psoriasis on risk of these CVDs. Methods A search of literature until 24 December 2021 was done in PubMed, the Cochrane Library, Web of Science, Google Scholar, and Embase. Within European and East Asian populations, meta-analyses of observational studies assessing correlations between psoriasis and various CVD risk factors were conducted. Mendelian randomization (MR) was then employed to assess the causative impact of genetic pre-disposition for psoriasis on these CVD risk factors. Results The results of the meta-analyses indicated that, in both the European and East Asian populations, psoriasis was significantly linked to an elevated risk in the incidence of CAD (RR = 1.51, 95% confidence interval (CI): 1.04–2.18, p = 0.028 and RR = 1.91, 95% CI: 1.62–2.25, p < 0.001) and MI (RR = 1.23, 95% CI: 1.04–1.46, p = 0.017 and RR = 2.17, 95% CI: 1.44–3.28, p < 0.001). A positive genetic relationship of psoriasis with CAD was found in European individuals (IVW OR:1.03; 95% CI: 1.01–1.06, p = 0.005) and in East Asian individuals (IVW OR:1.18; 95% CI: 1.03–1.32, p = 0.031). We also established that psoriasis was causally linked with an elevated risk of MI (IVW OR:1.05; 95% CI: 1.01–1.09, p = 0.026) in the European population as determined using an MR approach. Moreover, our MR results were congruent with the null findings from the meta-analysis assessing associations of psoriasis with HF risk. Conclusions This research work provides preliminary evidence that psoriasis and CVD have a common genetic origin and that targeted psoriasis treatment might improve cardiovascular outcomes. These results not only increase our knowledge of the genetic underpinnings linking a comorbidity of psoriasis with CVD but also suggests a novel approach for CVD prevention. Abstract Background Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF). However, available studies regarding this relationship have shown inconsistent results. Therefore, in this report, we performed a comprehensive review of the literature to assess the effects of psoriasis on risk of these CVDs. Methods A search of literature until 24 December 2021 was done in PubMed, the Cochrane Library, Web of Science, Google Scholar, and Embase. Within European and East Asian populations, meta-analyses of observational studies assessing correlations between psoriasis and various CVD risk factors were conducted. Mendelian randomization (MR) was then employed to assess the causative impact of genetic pre-disposition for psoriasis on these CVD risk factors. Results The results of the meta-analyses indicated that, in both the European and East Asian populations, psoriasis was significantly linked to an elevated risk in the incidence of CAD (RR = 1.51, 95% confidence interval (CI): 1.04–2.18, p = 0.028 and RR = 1.91, 95% CI: 1.62–2.25, p < 0.001) and MI (RR = 1.23, 95% CI: 1.04–1.46, p = 0.017 and RR = 2.17, 95% CI: 1.44–3.28, p < 0.001). A positive genetic relationship of psoriasis with CAD was found in European individuals (IVW OR:1.03; 95% CI: 1.01–1.06, p = 0.005) and in East Asian individuals (IVW OR:1.18; 95% CI: 1.03–1.32, p = 0.031). We also established that psoriasis was causally linked with an elevated risk of MI (IVW OR:1.05; 95% CI: 1.01–1.09, p = 0.026) in the European population as determined using an MR approach. Moreover, our MR results were congruent with the null findings from the meta-analysis assessing associations of psoriasis with HF risk. Conclusions This research work provides preliminary evidence that psoriasis and CVD have a common genetic origin and that targeted psoriasis treatment might improve cardiovascular outcomes. These results not only increase our knowledge of the genetic underpinnings linking a comorbidity of psoriasis with CVD but also suggests a novel approach for CVD prevention. |
| ArticleNumber | 421 |
| Audience | Academic |
| Author | Wang, Yuxiang Zhang, Liming Qiu, Li Wu, Jian |
| Author_xml | – sequence: 1 givenname: Liming orcidid: 0000-0002-9693-1082 surname: Zhang fullname: Zhang, Liming – sequence: 2 givenname: Yuxiang surname: Wang fullname: Wang, Yuxiang – sequence: 3 givenname: Li surname: Qiu fullname: Qiu, Li – sequence: 4 givenname: Jian surname: Wu fullname: Wu, Jian |
| BookMark | eNp9ks1u1DAUhSNUJNrCC7CKhITYpMROYscskEbVAJWKYAFr68a-nvGQ2IOdjNQ-Bk-MJ9NCp0LIsvz3neO_c5adOO8wy16S8oKQlr2NhArCipLSVBnhRfMkOyW8JgUvSXPyoP8sO4txU5a04bw-zX59jT5YiDbm4HSuIGjrdxDV1EPItY0IEfNg44_cunw5Bb9FcDO7hDjmi2jTcOu3iR-td_Fdjjur0SnMTfBDPuAIBTjob-73-IxOY7-XhTT0g72dlfk99Dx7aqCP-OKuPc--f1h-u_xUXH_5eHW5uC5Uw8lYNC3wRjRlV5W6BMTOlFApI3hlKKl0rYG1zFRVUyGwWkFlmOgYJcg0UbrT1Xl2dfDVHjZyG-wA4UZ6sHKe8GElIYxW9SjRdBUztGwEUzUSFBwIN5y1neCC0zZ5vT94baduQK3QjQH6I9PjFWfXcuV3UjDaloImgzd3BsH_nDCOcrBRYd-DQz9FSXlFaipq0ST01SN046eQHm-m0qFawdq_1ArSBawzPu2r9qZywWnd1jQZJuriH1QqGgerUsaMTfNHgtcPBGuEflxH30_z3x-D9ACq4GMMaP48BinlPrPykFmZMivnzMr91dpHImXHOR3pWLb_n_Q3Ir30bg |
| CitedBy_id | crossref_primary_10_1016_j_pnpbp_2024_111027 crossref_primary_10_15690_vsp_v22i5_2641 crossref_primary_10_1111_exd_15010 crossref_primary_10_2147_JIR_S492875 crossref_primary_10_3390_biology12111396 crossref_primary_10_1016_j_ypmed_2024_107893 crossref_primary_10_1515_medgen_2023_2005 crossref_primary_10_1093_bjd_ljad410 crossref_primary_10_2147_CCID_S450227 crossref_primary_10_1097_MD_0000000000040631 crossref_primary_10_1001_jamacardio_2024_2859 crossref_primary_10_3389_fimmu_2023_1288632 crossref_primary_10_31083_j_rcm2507262 crossref_primary_10_1016_j_amjms_2024_08_004 crossref_primary_10_1038_s41598_024_70707_w crossref_primary_10_1016_j_det_2024_02_007 crossref_primary_10_1186_s13098_024_01423_8 crossref_primary_10_1016_j_det_2024_02_005 crossref_primary_10_1038_s41435_023_00222_x crossref_primary_10_1186_s12888_025_06687_6 crossref_primary_10_3389_fimmu_2023_1272080 crossref_primary_10_2147_VHRM_S464471 crossref_primary_10_3389_fcvm_2023_1169474 crossref_primary_10_1007_s40259_025_00705_5 crossref_primary_10_3389_fimmu_2024_1459185 crossref_primary_10_3389_fmed_2024_1445288 crossref_primary_10_1007_s00403_024_03295_4 crossref_primary_10_1038_s41392_023_01655_6 crossref_primary_10_1161_JAHA_123_033893 crossref_primary_10_1016_j_pnpbp_2023_110903 crossref_primary_10_1001_jamacardio_2024_2868 crossref_primary_10_3389_fimmu_2024_1477587 crossref_primary_10_1093_braincomms_fcae077 |
| Cites_doi | 10.1016/j.jid.2017.10.001 10.1111/cei.12128 10.1111/joim.13311 10.1111/j.1468-3083.2009.03537.x 10.1016/j.amjmed.2015.05.041 10.1038/ng.2467 10.1038/jid.2015.218 10.1016/j.ebiom.2020.102956 10.1038/s41588-021-00931-x 10.1371/journal.pmed.1000097 10.1128/CVI.00163-07 10.1038/ng.311 10.1136/jmedgenet-2019-106200 10.1016/j.jaad.2010.01.050 10.1001/jamadermatol.2013.5015 10.1017/S0266462312000086 10.1001/jama.2017.8981 10.1161/CIRCRESAHA.117.312086 10.1038/jhh.2017.29 10.1161/HYPERTENSIONAHA.120.16589 10.1038/jid.2015.87 10.1038/ng.689 10.1038/ncomms7916 10.1161/CIRCGEN.119.002670 10.1089/dna.2013.2252 10.1089/cmb.2019.0180 10.1371/journal.pone.0149316 10.1038/ng.310 10.1016/j.ad.2014.08.002 10.1016/j.jclinepi.2019.10.011 10.1038/jid.2015.8 10.1111/j.1365-2796.2010.02310.x 10.1016/j.jid.2019.07.692 10.1038/ng.693 10.1002/ejhf.113 10.1016/j.ebiom.2020.103189 10.1007/s00403-006-0703-z 10.1111/j.1365-2133.2011.10494.x 10.1111/j.1365-2133.2006.07562.x 10.1038/ncomms15382 10.1111/j.1468-3083.2009.03318.x 10.1371/journal.pgen.1000041 10.1093/qjmed/hcab173 10.1038/ng.694 10.1016/j.ajhg.2014.12.004 10.1038/ncomms8001 10.1371/journal.pmed.0050177 10.1038/jid.2009.321 10.1056/NEJMoa1507652 10.1111/1346-8138.15052 10.1038/jid.2013.131 10.1111/j.1365-2133.2008.09020.x 10.1038/s41467-019-13690-5 10.1016/j.jjcc.2018.10.008 10.1016/j.jacc.2016.11.056 10.1038/ncomms7793 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022. The Author(s). The Author(s) 2022 |
| Copyright_xml | – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022. The Author(s). – notice: The Author(s) 2022 |
| DBID | AAYXX CITATION 3V. 7QL 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1186/s12916-022-02617-5 |
| DatabaseName | CrossRef ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Statistics |
| EISSN | 1741-7015 |
| EndPage | 11 |
| ExternalDocumentID | oai_doaj_org_article_efb36f20596c4e1e97a17f768b979728 PMC9628092 A724842314 10_1186_s12916_022_02617_5 |
| GeographicLocations | Asia Europe |
| GeographicLocations_xml | – name: Europe – name: Asia |
| GroupedDBID | --- 0R~ 23N 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB PMFND 3V. 7QL 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PJZUB PKEHL PPXIY PQEST PQUKI 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c571t-58a75950b30d0aeebf0a3cf973f213d4da686f3353ea64ca3f69b621e6d1cdbd3 |
| IEDL.DBID | M48 |
| ISSN | 1741-7015 |
| IngestDate | Wed Aug 27 01:31:56 EDT 2025 Thu Aug 21 18:39:01 EDT 2025 Fri Jul 11 10:19:47 EDT 2025 Sat Jul 26 02:21:49 EDT 2025 Tue Jun 17 21:44:18 EDT 2025 Tue Jun 10 20:25:33 EDT 2025 Thu May 22 21:21:56 EDT 2025 Thu Apr 24 23:11:14 EDT 2025 Tue Jul 01 02:51:32 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c571t-58a75950b30d0aeebf0a3cf973f213d4da686f3353ea64ca3f69b621e6d1cdbd3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-9693-1082 |
| OpenAccessLink | https://www.proquest.com/docview/2737688968?pq-origsite=%requestingapplication% |
| PQID | 2737688968 |
| PQPubID | 42775 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_efb36f20596c4e1e97a17f768b979728 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9628092 proquest_miscellaneous_2731429495 proquest_journals_2737688968 gale_infotracmisc_A724842314 gale_infotracacademiconefile_A724842314 gale_healthsolutions_A724842314 crossref_primary_10_1186_s12916_022_02617_5 crossref_citationtrail_10_1186_s12916_022_02617_5 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-11-01 |
| PublicationDateYYYYMMDD | 2022-11-01 |
| PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London |
| PublicationTitle | BMC medicine |
| PublicationYear | 2022 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | LC Tsoi (2617_CR24) 2017; 8 A Morrison (2617_CR58) 2012; 28 NG Masca (2617_CR31) 2016; 374 2617_CR7 H Chen (2617_CR53) 2013; 173 M Koch (2617_CR4) 2015; 135 J Xiao (2617_CR44) 2009; 23 H Baurecht (2617_CR21) 2015; 96 EA Dowlatshahi (2617_CR6) 2013; 133 S Shah (2617_CR33) 2020; 11 M Qi (2617_CR1) 2014; 33 L Mahiques-Santos (2617_CR39) 2015; 106 LD Ji (2617_CR54) 2017; 31 D Moher (2617_CR14) 2009; 6 O Ahlehoff (2617_CR50) 2011; 270 S Sakaue (2617_CR35) 2021; 53 GA Wells (2617_CR15) 2019 H Yeung (2617_CR48) 2013; 149 A Palikhe (2617_CR56) 2008; 15 X Zuo (2617_CR28) 2015; 6 M Wakkee (2617_CR43) 2010; 130 YB Brauchli (2617_CR45) 2009; 160 KJ Jung (2617_CR2) 2019; 46 Y Lu (2617_CR9) 2020; 57 XJ Zhang (2617_CR26) 2009; 41 P van der Harst (2617_CR30) 2018; 122 E Ellinghaus (2617_CR20) 2010; 42 HW Lin (2617_CR47) 2011; 64 U Khalid (2617_CR51) 2014; 16 A Strange (2617_CR18) 2010; 42 RJ Ludwig (2617_CR37) 2007; 156 M Shiba (2617_CR3) 2016; 11 CA Klemens (2617_CR55) 2021; 77 AB Tinggaard (2617_CR41) 2021; 290 C Yang (2617_CR29) 2020; 140 M Shiba (2617_CR49) 2019; 73 LC Tsoi (2617_CR25) 2012; 44 A Ogdie (2617_CR8) 2015; 135 J Hirata (2617_CR27) 2018; 138 Y Liu (2617_CR16) 2008; 4 DM Sommer (2617_CR36) 2006; 29 G Zhang (2617_CR52) 2020; 27 W Li (2617_CR57) 2022; 2022 C Yan (2617_CR40) 2012; 45 SC Larsson (2617_CR11) 2017; 318 R Parisi (2617_CR5) 2015; 135 PE Stuart (2617_CR19) 2010; 42 TR Webb (2617_CR32) 2017; 69 J Schmitt (2617_CR46) 2010; 24 KF Hjuler (2617_CR38) 2015; 128 T Zhang (2617_CR12) 2021; 63 S Yuan (2617_CR13) 2020; 59 RP Nair (2617_CR17) 2009; 41 H Matsunaga (2617_CR34) 2020; 13 X Yin (2617_CR22) 2015; 6 YW Yang (2617_CR42) 2011; 165 B Nussbaumer-Streit (2617_CR59) 2020; 118 LC Tsoi (2617_CR23) 2015; 6 NA Sheehan (2617_CR10) 2008; 5 |
| References_xml | – volume: 138 start-page: 542 year: 2018 ident: 2617_CR27 publication-title: J Invest Dermatol doi: 10.1016/j.jid.2017.10.001 – volume: 173 start-page: 544 year: 2013 ident: 2617_CR53 publication-title: Clin Exp Immunol doi: 10.1111/cei.12128 – volume: 290 start-page: 693 year: 2021 ident: 2617_CR41 publication-title: J Intern Med doi: 10.1111/joim.13311 – volume: 24 start-page: 885 year: 2010 ident: 2617_CR46 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/j.1468-3083.2009.03537.x – volume: 128 start-page: 1325 year: 2015 ident: 2617_CR38 publication-title: Am J Med doi: 10.1016/j.amjmed.2015.05.041 – volume: 44 start-page: 1341 year: 2012 ident: 2617_CR25 publication-title: Nat Genet doi: 10.1038/ng.2467 – volume: 135 start-page: 2148 year: 2015 ident: 2617_CR8 publication-title: J Invest Dermatol doi: 10.1038/jid.2015.218 – volume: 59 year: 2020 ident: 2617_CR13 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.102956 – volume: 53 start-page: 1415 year: 2021 ident: 2617_CR35 publication-title: Nat Genet doi: 10.1038/s41588-021-00931-x – volume: 6 start-page: e1000097 year: 2009 ident: 2617_CR14 publication-title: PLoS Med. doi: 10.1371/journal.pmed.1000097 – volume: 15 start-page: 55 year: 2008 ident: 2617_CR56 publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00163-07 – volume: 41 start-page: 199 year: 2009 ident: 2617_CR17 publication-title: Nat Genet doi: 10.1038/ng.311 – volume: 57 start-page: 820 year: 2020 ident: 2617_CR9 publication-title: J Med Genet doi: 10.1136/jmedgenet-2019-106200 – volume: 64 start-page: 495 year: 2011 ident: 2617_CR47 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2010.01.050 – volume: 149 start-page: 1173 year: 2013 ident: 2617_CR48 publication-title: JAMA Dermatol doi: 10.1001/jamadermatol.2013.5015 – volume: 28 start-page: 138 year: 2012 ident: 2617_CR58 publication-title: Int J Technol Assess Health Care doi: 10.1017/S0266462312000086 – volume: 318 start-page: 371 year: 2017 ident: 2617_CR11 publication-title: JAMA doi: 10.1001/jama.2017.8981 – volume: 122 start-page: 433 year: 2018 ident: 2617_CR30 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.117.312086 – volume: 31 start-page: 695 year: 2017 ident: 2617_CR54 publication-title: J Hum Hypertens doi: 10.1038/jhh.2017.29 – volume: 77 start-page: 582 year: 2021 ident: 2617_CR55 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.120.16589 – volume: 135 start-page: 2189 year: 2015 ident: 2617_CR5 publication-title: J Invest Dermatol. doi: 10.1038/jid.2015.87 – volume: 42 start-page: 991 year: 2010 ident: 2617_CR20 publication-title: Nat Genet. doi: 10.1038/ng.689 – volume: 6 start-page: 6916 year: 2015 ident: 2617_CR22 publication-title: Nat Commun doi: 10.1038/ncomms7916 – volume: 13 year: 2020 ident: 2617_CR34 publication-title: Circ Genom Precis Med doi: 10.1161/CIRCGEN.119.002670 – volume: 33 start-page: 234 year: 2014 ident: 2617_CR1 publication-title: DNA Cell Biol doi: 10.1089/dna.2013.2252 – volume: 27 start-page: 779 year: 2020 ident: 2617_CR52 publication-title: J Comput Biol doi: 10.1089/cmb.2019.0180 – volume: 11 year: 2016 ident: 2617_CR3 publication-title: PLoS ONE doi: 10.1371/journal.pone.0149316 – volume: 41 start-page: 205 year: 2009 ident: 2617_CR26 publication-title: Nat Genet doi: 10.1038/ng.310 – volume: 45 start-page: 627 year: 2012 ident: 2617_CR40 publication-title: Chin J Dermatol. – volume: 106 start-page: 112 year: 2015 ident: 2617_CR39 publication-title: Actas Dermosifiliogr doi: 10.1016/j.ad.2014.08.002 – volume: 118 start-page: 42 year: 2020 ident: 2617_CR59 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2019.10.011 – volume: 135 start-page: 1283 year: 2015 ident: 2617_CR4 publication-title: J Invest Dermatol doi: 10.1038/jid.2015.8 – volume: 270 start-page: 147 year: 2011 ident: 2617_CR50 publication-title: J Intern Med doi: 10.1111/j.1365-2796.2010.02310.x – volume: 140 start-page: 799 year: 2020 ident: 2617_CR29 publication-title: J Invest Dermatol doi: 10.1016/j.jid.2019.07.692 – volume: 42 start-page: 1000 year: 2010 ident: 2617_CR19 publication-title: Nat Genet doi: 10.1038/ng.693 – volume: 16 start-page: 743 year: 2014 ident: 2617_CR51 publication-title: Eur J Heart Fail doi: 10.1002/ejhf.113 – volume: 63 year: 2021 ident: 2617_CR12 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.103189 – volume: 29 start-page: 321 year: 2006 ident: 2617_CR36 publication-title: Arch Dermatol Res doi: 10.1007/s00403-006-0703-z – volume: 165 start-page: 1037 year: 2011 ident: 2617_CR42 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2011.10494.x – volume: 156 start-page: 271 year: 2007 ident: 2617_CR37 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2006.07562.x – volume: 8 start-page: 15382 year: 2017 ident: 2617_CR24 publication-title: Nat Commun doi: 10.1038/ncomms15382 – volume: 23 start-page: 1311 year: 2009 ident: 2617_CR44 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/j.1468-3083.2009.03318.x – volume: 4 year: 2008 ident: 2617_CR16 publication-title: PLoS Genet doi: 10.1371/journal.pgen.1000041 – ident: 2617_CR7 doi: 10.1093/qjmed/hcab173 – volume: 42 start-page: 985 year: 2010 ident: 2617_CR18 publication-title: Nat Genet. doi: 10.1038/ng.694 – volume: 2022 start-page: 2538769 year: 2022 ident: 2617_CR57 publication-title: Healthc Eng – volume: 96 start-page: 104 year: 2015 ident: 2617_CR21 publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2014.12.004 – volume: 6 start-page: 7001 year: 2015 ident: 2617_CR23 publication-title: Nat Commun doi: 10.1038/ncomms8001 – volume: 5 year: 2008 ident: 2617_CR10 publication-title: PLoS Med doi: 10.1371/journal.pmed.0050177 – volume: 130 start-page: 962 year: 2010 ident: 2617_CR43 publication-title: J Invest Dermatol doi: 10.1038/jid.2009.321 – volume: 374 start-page: 1134 year: 2016 ident: 2617_CR31 publication-title: N Engl J Med doi: 10.1056/NEJMoa1507652 – volume: 46 start-page: 859 year: 2019 ident: 2617_CR2 publication-title: J Dermatol. doi: 10.1111/1346-8138.15052 – volume: 133 start-page: 2347 year: 2013 ident: 2617_CR6 publication-title: J Invest Dermatol doi: 10.1038/jid.2013.131 – volume: 160 start-page: 1048 year: 2009 ident: 2617_CR45 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2008.09020.x – volume: 11 start-page: 163 year: 2020 ident: 2617_CR33 publication-title: Nat Commun doi: 10.1038/s41467-019-13690-5 – volume: 73 start-page: 276 year: 2019 ident: 2617_CR49 publication-title: J Cardiol doi: 10.1016/j.jjcc.2018.10.008 – volume: 69 start-page: 823 year: 2017 ident: 2617_CR32 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.11.056 – volume: 6 start-page: 6793 year: 2015 ident: 2617_CR28 publication-title: Nat Commun doi: 10.1038/ncomms7793 – volume-title: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses year: 2019 ident: 2617_CR15 |
| SSID | ssj0025774 |
| Score | 2.5234966 |
| SecondaryResourceType | review_article |
| Snippet | Background Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure... Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF).... Abstract Background Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart... |
| SourceID | doaj pubmedcentral proquest gale crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | 1 |
| SubjectTerms | Body mass index Cardiovascular disease Cardiovascular diseases Comorbidity Complications and side effects Confidence intervals Congestive heart failure Consortia Coronary artery disease Coronary vessels Demographic aspects Diabetes Epidemiology Genetic relationship Genomes Health risks Heart diseases Heart failure Literature reviews Mendelian randomization Meta-analysis Myocardial infarction Population studies Populations Psoriasis Randomization Risk analysis Risk factors Skin diseases Statistics Vein & artery diseases |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_Sg3gRP_FpqxEED7L0ZfO16e0pLUV44sFCbyFfiw_svtLd_iP-xc5ks0tXQS9eNxPITmYyM8n8Zgh5B05qlKBEVUrCV0LxtnIRYh7hEhcNxBM6Id55-0WdX4jPl_LyTqsvzAkbywOPjDtOreeqrbFLTBCJJaMd0y04yd5oo-sM8wWbNwVTJdSS4NVMEJlGHfdg1Rgm29ZVLkFeyYUZytX6_zyTf8-TvGN4zh6Rh8VjpJtxpY_JvdQ9Ife35U38Kfn5td-DFPW7nrou0rBIMKXlAYZiCjnddXS6fc-0p64f6AZhlPR6buTVn9BUWo1SBJ_QqzS4ypXiJXneFu_N8X6EgqWL-6uC5aQT0TNycXb67dN5VTotVEFqNlSycVoaufZ8HdcuJd-uHQ-t0bytGY8iOtWolnPJk1MiON4q41XNkoosRB_5c3LQ7bv0gtAQPLhY0fgGn4rB2mmndVSaOe7ANTUrwibG21DKkGM3jB82hyONsuNmWdgsmzfLyhX5MM-5Hotw_JX6I-7nTIkFtPMHECtbxMr-S6xW5A1Kgx3RqPMxYDe6Fg24oEysyPtMgQcB_EBwBc8AbMCSWgvKwwUlKHBYDk8SZ8sB0lvwKmExjVGwkrfzMM7EpLgu7W8zDQMGQ4i7InohqYt_X450u--5iLhRNahi_fJ_MOsVeVCjbmWI5iE5GG5u0xH4aoN_ndXyF0vxPOo priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0gvRFtCrGVl1B8EFCb7PJ7sYXOaWlCCc-WLi3Zb-iB21yNuk_4l_cmc3mahT6ejvLJZnPnZ35DSHvIEj1FShRHkJp81LwJjcezjylCbxUcJ6QAfudV9_E2Xn5dV2tU8KtT2WVk02Mhtp3DnPkx-BmITJWtVCftr9znBqFt6tphMZ98gChy1Cq5fr2wFVBbDM1yihx3INvY1hyW-QRiDyvZs4oYvb_b5n_rZb8y_2cPiaPUtxIlyOjn5B7oT0gD1fpZvyA7GPUOIIuPyV_vvfw6Kbf9NS0nrpZzSlNdzIUq8rppqVTQj7Snph-oEvsrKTb3Wyv_iMNafooxX4UehkGk5uEZxL3rTCVjikTCs7Pd5epvZNORM_I-enJjy9neRq-kLtKsiGvlJFVXS0sX_iFCcE2C8NdU0veFIz70huhRMN5xYMRpTO8EbUVBQvCM-et58_JXtu14QWhzlmIunxtFd4egwOURkovJDPcQLRaZ4RNXNAuIZPjgIwLHU8oSuiRcxo4pyPndJWRD7s92xGX407qz8jcHSViascfuqufOqmoDo3loilwHpErAwvwmEw2IHS2lrUsVEbeoGjosUF1Zxn0UhalgqiUlRl5HynQNsALOJNaHOAzIMrWjPJoRgk67ebLk_jpZFN6fasBGXm7W8adWCfXhu460jD4wHDqzYicie3s3ecr7eZXxBWvRQHaWby8-88PyX6BKhT7MY_I3nB1HV5BYDbY11H7bgBU1DlG priority: 102 providerName: ProQuest |
| Title | Psoriasis and cardiovascular disease risk in European and East Asian populations: evidence from meta-analysis and Mendelian randomization analysis |
| URI | https://www.proquest.com/docview/2737688968 https://www.proquest.com/docview/2731429495 https://pubmed.ncbi.nlm.nih.gov/PMC9628092 https://doaj.org/article/efb36f20596c4e1e97a17f768b979728 |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA_3AeKL-In1zjWC4INEN02atILIruxxCHschwuLLyFN0nPhrj23e3D-G_7FTrJpsXoIvuxDM1nSyUxnJpn5DUKvwEm1GSgRcY6XhAtWEW0h5uHaMZ5DPCGdr3een4jjBf-8zJY7qGt3FBnY3hra-X5Si_XF25vvPz6Cwn8ICp-Ldy3YLOpTaVMSAMZJtov2wTJJ39FgzvtbBZDOgMoMTjglEuxgV0Rz638MDFXA8__7q_1nJuVvpunoProXfUo82QrBA7Tj6ofozjzemj9CP0_bBuSsXbVY1xabQQoqjlc02CeZ41WNu_P5QDvT7QZPfKElvupbfbXvsYvNSLEvT8GXbqOJjvAmYd7cn6z7ExQMttA2l7HaE3dEj9HiaPbl0zGJvRiIySTdkCzXMiuyccnGdqydK6uxZqYqJKtSyiy3WuSiYixjTgtuNKtEUYqUOmGpsaVlT9Be3dTuKcLGlOCE2aLM_WUy2EOppbRCUs00OK9FgmjHeGUiULnvl3GhQsCSC7XdLAWbpcJmqSxBb_o5V1uYjn9ST_1-9pQeYjs8aNbnKmqsclXJRJX69kSGO-pgmVRWEJ2VhSxkmifohZcGta1X7T8UaiJTnoOTSnmCXgcKL7zwAkbHigdggwfdGlAeDihBxc1wuJM41WmIAr8TFpMXAlbysh_2M33aXO2a60BDgcEQBCdIDiR18O7DkXr1LcCMFyIFZU2f_RdrD9Dd1CtRqNY8RHub9bV7Dm7bphyhXbmUI7Q_nZ2cno3C4cco6Cf8nk2__gLpjkId |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1Nb9Mw1BpDgl0QDNACgxkJxAFFi-PETpAQKrCpY-vEYZN6M47tQCWWlqUT4m_wQ_iNvOc4HQFpt13r56Tx-_b7IuQ5GKk2ByaKncuqOBO8jrUFnyfTjmcF-BPSYb3z5FiMT7OP03y6Rn73tTCYVtnLRC-o7dzgHfkuqFmwjItSFG8X32OcGoXR1X6ERkcWh-7nD3DZ2jcHHwC_L9J0f-_k_TgOUwVik0u2jPNCy7zMk4onNtHOVXWiualLyeuUcZtZLQpRc55zp0VmNK9FWYmUOWGZsZXl8Nwb5CYo3gSdPTm9dPBysKX6wpxC7LagSxmm-Kaxb3we5wPl52cE_K8J_s3O_Evd7d8ld4KdSkcdYd0ja67ZJLcmIRK_STbQSu2aPN8nvz61cFS6nbVUN5aaQY4rDTEgilnsdNbQPgDgYfd0u6QjrOSki9UssfY1dWHaKcX6F3rmljrWoX-K3zfBq3u8oqGgbO38LJST0h7oATm9FrQ8JOvNvHFbhBpTgZVny6rAaDUoXKmltEIyzTVYx2VEWI8FZUIndBzI8U15j6gQqsOcAswpjzmVR-TVas-i6wNyJfQ7RO4KEnt4-x_m519UEAnK1RUXdYrzj0zmmIO_yWQNRF6VspRpEZEdJA3VFcSuJJEayTQrwApmWUReegiURfABRoeSCjgG7Oo1gNweQIIMMcPlnvxUkGGtuuS4iDxbLeNOzMtr3PzCwzA4YPCyIyIHZDv49uFKM_vq-5iXIgVpkD66-uU75Pb4ZHKkjg6ODx-TjRTZydeCbpP15fmFewJG4bJ66jmRks_Xzfp_ACOjd08 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psoriasis+and+cardiovascular+disease+risk+in+European+and+East+Asian+populations%3A+evidence+from+meta-analysis+and+Mendelian+randomization+analysis&rft.jtitle=BMC+medicine&rft.au=Zhang%2C+Liming&rft.au=Wang%2C+Yuxiang&rft.au=Qiu%2C+Li&rft.au=Wu%2C+Jian&rft.date=2022-11-01&rft.issn=1741-7015&rft.eissn=1741-7015&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12916-022-02617-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12916_022_02617_5 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1741-7015&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1741-7015&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1741-7015&client=summon |